AVDL logo

Avadel Pharmaceuticals plc (AVDL)

Profile

Full Name

Avadel Pharmaceuticals plc

Ticker

NASDAQ: AVDL

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

Ireland

IPO

June 7, 1996

Indexes

Not included

Website

https://www.avadel.com

Employees

188

Key Details

Price

$13.69(+1.41%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$169.12M(+504.79% YoY)

Annual EPS

$0.00(0.00% YoY)

PE ratio

273.80

Next earnings date

Nov 10, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $13.69
    AVDL price is $13.69

    30-Day Relative Volume

    0.89
    AVDL 30-day relative volume is 0.89

    Price Performance

    Price Most recent change

    +1.41%
    AVDL price was up +1.41% on Aug 15, 2025

    Price YTD change

    +30.26%
    AVDL price is up +30.26% since January 1st

    Price 1-year change

    -10.81%
    AVDL price is down -10.81% year-on-year

    Price 3-year change

    +99.27%
    AVDL price is up +99.27% over the past 3 years

    Price Range

    Price All-time high

    $43.60
    AVDL price is currently -68.60% below its historical high of $43.60

    Price 3-year low

    $4.61
    AVDL price is currently +196.96% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.33B
    AVDL market capitalization is $1.33 billion

    Market cap 3-year change

    +223.6%
    AVDL market capitalization is up +223.6% over the past 3 years

    Market cap All-time high

    $1.81B
    AVDL market capitalization is currently -26.50% below its historical high of $1.81 billion

    Market cap sector rank

    77.03%
    AVDL market capitalization is higher than 77.03% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.86%
    AVDL shares outstanding is up +0.86% year-on-year

    Shares Outstanding 3-Year Change

    +62.39%
    AVDL shares outstanding is up +62.39% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.81
    AVDL beta is 0.81

    200-day SMA

    $9.68
    AVDL price is currently +41.38% above its 200-day simple moving average

    50-day SMA

    $10.46
    AVDL price is currently +30.84% above its 50-day simple moving average

    RSI

    78.07
    AVDL 14-day relative strength index is 78.07

    Volume

    0.89
    AVDL 30-day relative volume is 0.89

    ATR

    $0.60
    AVDL average true range is $0.60

    10-day Historical Volatility

    76.38%
    AVDL 10-day historical volatility is 76.38%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $169.12M
    AVDL annual revenue is $169.12 million

    Revenue Analysts estimate

    $271.55M
    AVDL annual revenue is currently -37.72% lower than the consensus analysts' forecast

    Revenue 1-year change

    +504.79%
    AVDL annual revenue is up +504.79% year-on-year

    Revenue Sector rank

    72.41%
    AVDL annual revenue is higher than 72.41% of companies in Healthcare sector

    EPS

    EPS

    $0.00
    AVDL annual earnings per share is $0.00

    EPS Analysts estimate

    $0.25
    AVDL annual earnings per share is currently -100.00% lower than the consensus analysts' forecast

    EPS 1-year change

    0%
    AVDL annual earnings per share has remained unchanged year-on-year

    EPS Sector rank

    82.49%
    AVDL annual earnings per share is higher than 82.49% of companies in Healthcare sector

    Profit

    Gross profit

    $153.84M
    AVDL annual gross profit is $153.84 million

    Gross margin

    90.97%
    AVDL annual gross profit margin is 90.97%

    Operating profit

    -$42.40M
    AVDL annual operating income is -$42.40 million

    Operating margin

    -25.07%
    AVDL annual operating profit margin is -25.07%

    Net income

    -$48.83M
    AVDL annual net profit is -$48.83 million

    Net margin

    -28.87%
    AVDL annual net profit margin is -28.87%

    Expenses

    Total expenses

    $211.52M
    AVDL annual total expenses is $211.52 million

    Operating expenses

    $196.24M
    AVDL annual total operating expenses is $196.24 million

    Cost of goods sold

    $15.28M
    AVDL annual cost of goods sold is $15.28 million

    Selling, general & administrative expenses

    $181.04M
    AVDL annual SGA is $181.04 million

    Depreciation and amortization

    $2.68M
    AVDL annual depreciation & amortization is $2.68 million

    Interest expense

    $0.00
    AVDL annual interest expense is $0.00

    Income tax

    -$247.00K
    AVDL annual income tax is -$247.00 thousand

    EBIT & EBITDA

    EBIT

    -$38.25M
    AVDL annual earnings before interest & taxes is -$38.25 million

    EBITDA

    -$35.57M
    AVDL annual EBITDA is -$35.57 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $265.80M
    AVDL annual total assets is $265.80 million

    Non current assets

    $30.03M
    AVDL annual long term assets is $30.03 million

    Current assets

    $134.21M
    AVDL annual total current assets is $134.21 million

    Cash and cash equivalents

    $51.37M
    AVDL annual cash & cash equivalents is $51.37 million

    Accounts receivable

    $34.10M
    AVDL annual accounts receivable is $34.10 million

    Inventory

    $20.30M
    AVDL annual inventory is $20.30 million

    Liabilities

    Total liabilities

    $191.95M
    AVDL annual total liabilities is $191.95 million

    Long term liabilities

    $41.55M
    AVDL annual total long term liabilities is $41.55 million

    Current liabilities

    $48.83M
    AVDL annual total current liabilities is $48.83 million

    Accounts payable

    $7.33M
    AVDL annual accounts payable is $7.33 million

    Debt

    Total debt

    $1.70M
    AVDL annual total debt is $1.70 million

    Total debt 1-year change

    -35.06%
    AVDL annual total debt is down -35.06% year-on-year

    Long term debt

    $1.12M
    AVDL annual long term debt is $1.12 million

    Short term debt

    $582.00K
    AVDL annual short term debt is $582.00 thousand

    Equity & Capital

    Shareholders equity

    $73.85M
    AVDL annual stockholders equity is $73.85 million

    Book value

    $73.85M
    AVDL annual book value is $73.85 million

    Retained earnings

    -$794.33M
    AVDL annual retained earnings is -$794.33 million

    Working capital

    $85.37M
    AVDL annual working capital is $85.37 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$46.91M
    AVDL annual cash flow from operations is -$46.91 million

    Cash from operations 1-year change

    +63.5%
    AVDL annual cash flow from operations is up +63.5% year-on-year

    Cash from investing

    $51.78M
    AVDL annual cash flow from investing activities is $51.78 million

    Cash from investing 1-year change

    +203.37%
    AVDL annual cash flow from investing activities is up +203.37% year-on-year

    Cash from financing

    $15.97M
    AVDL annual cash flow from financing activities is $15.97 million

    Cash from financing 1-year change

    -88.2%
    AVDL annual cash flow from financing activities is down -88.2% year-on-year

    CAPEX

    CAPEX

    $0.00
    AVDL annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    AVDL annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$46.91M
    AVDL annual free cash flow is -$46.91 million

    Free cash flow 1-year change

    +63.5%
    AVDL annual free cash flow is up +63.5% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    90.97%
    AVDL annual gross profit margin is 90.97%

    Operating margin

    -25.07%
    AVDL annual operating profit margin is -25.07%

    Net margin

    -28.87%
    AVDL annual net profit margin is -28.87%

    ROA & ROE

    ROA

    -18.53%
    AVDL annual return on assets is -18.53%

    ROE

    -60.44%
    AVDL annual return on equity is -60.44%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    273.80
    AVDL price to earnings ratio is 273.80

    PE ratio Sector rank

    96.7%
    AVDL price to earnings ratio is higher than 96.7% of companies in Healthcare sector

    PB Ratio

    PB ratio

    14.65
    AVDL price to book ratio is 14.65

    PB ratio Sector rank

    93.24%
    AVDL price to book ratio is higher than 93.24% of companies in Healthcare sector

    PS Ratio

    PS ratio

    6.01
    AVDL price to sales ratio is 6.01

    PS ratio Sector rank

    63.24%
    AVDL price to sales ratio is higher than 63.24% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.27B
    AVDL enterprise value is $1.27 billion

    Enterprise value Sector rank

    74.05%
    AVDL enterprise value is higher than 74.05% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    161.32
    AVDL EV/EBITDA is 161.32

    EV/EBITDA Sector rank

    98.93%
    AVDL EV/EBITDA is higher than 98.93% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.75
    AVDL annual current ratio is 2.75

    Quick ratio

    2.33
    AVDL annual quick ratio is 2.33

    Leverage

    Debt to equity

    0.00
    AVDL annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    AVDL annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    3
    AVDL piotroski f-score is 3

    Altman Z-Score

    0.52
    AVDL altman z-score is 0.52

    Analyst ratings

    Recent major analysts updates

    Aug 8, 25 HC Wainwright & Co.
    Buy
    May 8, 25 Needham
    Buy
    Apr 9, 25 Needham
    Buy
    Mar 4, 25 Needham
    Buy
    Mar 4, 25 HC Wainwright & Co.
    Buy
    Mar 3, 25 Needham
    Buy
    Feb 11, 25 Deutsche Bank
    Buy
    Jan 13, 25 UBS
    Buy
    Jan 10, 25 Piper Sandler
    Overweight
    Jan 10, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with AVDL included

    Growing Shares Outstanding
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Avadel Pharmaceuticals plc?
    • Does Avadel Pharmaceuticals plc pay dividends?
    • What sector is Avadel Pharmaceuticals plc in?
    • What industry is Avadel Pharmaceuticals plc in?
    • What country is Avadel Pharmaceuticals plc based in?
    • When did Avadel Pharmaceuticals plc go public?
    • Is Avadel Pharmaceuticals plc in the S&P 500?
    • Is Avadel Pharmaceuticals plc in the NASDAQ 100?
    • Is Avadel Pharmaceuticals plc in the Dow Jones?
    • When was Avadel Pharmaceuticals plc's last earnings report?
    • When does Avadel Pharmaceuticals plc report earnings?

    What is the ticker symbol for Avadel Pharmaceuticals plc?

    The ticker symbol for Avadel Pharmaceuticals plc is NASDAQ:AVDL

    Does Avadel Pharmaceuticals plc pay dividends?

    No, Avadel Pharmaceuticals plc does not pay dividends

    What sector is Avadel Pharmaceuticals plc in?

    Avadel Pharmaceuticals plc is in the Healthcare sector

    What industry is Avadel Pharmaceuticals plc in?

    Avadel Pharmaceuticals plc is in the Specialty & Generic Drug Manufacturers industry

    What country is Avadel Pharmaceuticals plc based in?

    Avadel Pharmaceuticals plc is headquartered in Ireland

    When did Avadel Pharmaceuticals plc go public?

    Avadel Pharmaceuticals plc's initial public offering (IPO) was on June 7, 1996

    Is Avadel Pharmaceuticals plc in the S&P 500?

    No, Avadel Pharmaceuticals plc is not included in the S&P 500 index

    Is Avadel Pharmaceuticals plc in the NASDAQ 100?

    No, Avadel Pharmaceuticals plc is not included in the NASDAQ 100 index

    Is Avadel Pharmaceuticals plc in the Dow Jones?

    No, Avadel Pharmaceuticals plc is not included in the Dow Jones index

    When was Avadel Pharmaceuticals plc's last earnings report?

    Avadel Pharmaceuticals plc's most recent earnings report was on August 7, 2025

    When does Avadel Pharmaceuticals plc report earnings?

    The next expected earnings date for Avadel Pharmaceuticals plc is November 10, 2025
    On this page